| |
 |
First Opinion contributors kicked off the first full week of 2022 with a bang, taking on topics ranging from resigning from a Covid-19 vaccine trial to the urgency of treating obesity as a disease instead of viewing it as a moral failure. You can read them all here. |
| |
| By Jeremy Menchik Mark Lennihan/AP I volunteered to be in trials of the Moderna vaccine. I wouldn't have if I had known about the company's relentless quest for profits. Read More |
| By Fatima Cody Stanford and Kelly Copes-Anderson Patrick Sison/AP It's time to take action on the Treat and Reduce Obesity Act, which will help people with obesity get the treatment they need. Read More |
| By Harris Solomon JOSEPH PREZIOSO/AFP via Getty Images Health care workers in short-staffed ICUs need fair wages, policies that sustain safe workplaces, and not having their work taken for granted. Read More |
| Sponsor content by STAT+ Biopharma breakthroughs, business, and policy analysis — at your fingertips Enjoy daily, market-moving analysis of the biotech, pharma, and life sciences industries with STAT Plus. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond. Don't be the last to know. Subscribe today to start reading. |
| By Elliott J. Millenson Scott Olson/Getty Images The key marker of effectiveness for home Covid-19 tests should be few false negatives, rather than the fewest false positives. Read More |
| By Reshma Ramachandran and Tianna Zhou and Joseph S. Ross Adobe For Medicare-covered seniors with chronic conditions, out-of-pocket costs for medications increased by more than 40% between 2009 and 2019. Read More |
| By Gregory D. Stevens JOSEPH PREZIOSO/AFP via Getty Images "Protect the NHS" has been an effective vaccination call to action in the U.K. "Protect our hospitals" won't work well in the U.S. Read More |
| By Donald Norcross David Keyton/AP The Opioid Treatment Access Act would improve access to and modernize the delivery of methadone for people with opioid use disorder. Read More |
| By Peter Arno and Robert Sachs and Kathryn Ardizzone Anne Weston/Francis Crick Institute/Wellcome A petition asking HHS to exercise lawful march-in rights for the prostate cancer drug Xtandi has languished since 2019. It needs action. Read More |
| By David Stein Kristoffer Tripplaar/AP The health care technology community must learn from — and move past — the Theranos debacle to help patients benefit from new technologies. Read More |
| By Jeffrey A. Lieberman Andrew Harnik/AP Three senators' "concerns" about Robert Califf show a disturbing lack of understanding of the experience needed to lead the FDA. Read More |
No comments